Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03298802Phase 3Terminated
A Phase 3 trial of hydrochlorothiazide in preeclampsia, gestational hypertension (GH), sponsored by The University of Texas Medical Branch at Galveston. Started Nov 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03298802.